hsa-mir-610: hsa-mir-610 is a microRNA that exhibits differential expression patterns influenced by the p53 status, being downregulated by mutant p53 and upregulated by wild-type p53 [PMC4905457]. It has been identified as a potential biomarker for favorable prognosis in patients, as it is overexpressed in those with good World Federation of Neurosurgical Societies (WFNS) grades at admission and positive outcomes at three months [PMC9732100]. In various studies, hsa-mir-610 has been shown to be upregulated in certain conditions, such as in the presence of progesterone support [PMC3462109], while it is downregulated or underexpressed in others, including comparisons between serum and cerebrospinal fluid (CSF) [PMC9738832], and between primary adrenocortical carcinoma (ACC) tissues and normal salivary gland tissues [PMC5929417]. Additionally, hsa-mir-610 is part of a constructed miRNA‒mRNA network that could be relevant for understanding miRNA‒mRNA interactions [PMC9676937], and specific primers for hsa-mir-610 are available for research purposes to facilitate its study [PMC5722568].